Stig Hansen is the founder of Carmot Therapeutics. Carmot Therapeutics has raised $55M in total funding. Latest round: Series A.
Stig Hansen is the Co-founder, President, and CEO of Kimia Therapeutics. He founded Kimia Therapeutics after leading Carmot Therapeutics, which was acquired by Roche in January 2024 for up to $3.1 billion. In December 2023, Hansen raised $55 million in Series A funding for Kimia Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library